Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma

A small subset of patients with nodular lymphocyte-predominant Hodgkin's lymphoma (NLPHLs) develop a non-Hodgkin lymphoma either concurrently or subsequently, usually T-cell/histiocyte-rich B-cell lymphomas (T/HRBCL), which are subtypes of diffuse large B-cell lymphomas (DLBCL). The standard tr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Park, Hyung-Chul, Jung, Sung-Hoon, Ahn, Jae-Sook, Kim, Mi-Young, Yang, Deok-Hwan, Kim, Yeo-Kyeoung, Kim, Hyeoung-Joon, Lee, Je-Jung
Format: Artigo
Sprache:Inglês
Veröffentlicht: S. Karger AG 2012
Schlagworte:
Published online: August, 2012
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3433022/
https://ncbi.nlm.nih.gov/pubmed/22949903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000341562
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge